SCHEMBL18010368

SCHEMBL18010368

COc1ccccc1N1CCN(CCCCn2c3ccccc3c3ccccc32)CC1

nearest known ligand 0.71

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 15/20 0.70
HTR1A P08908 13/20 0.70
HTR1D P28221 4/20 0.70
HTR1B P28222 4/20 0.70
HTR2A P28223 4/20 0.70
HTR2C P28335 4/20 0.70
HTR2B P41595 4/20 0.70
HTR5A P47898 2/20 0.70
KCNH2 Q12809 2/20 0.69
DRD2 P14416 1/20 0.67
DRD3 P35462 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18028066 0.99 HTR7 (0.71) HTR7HTR1AHTR1DHTR1BHTR2A
SCHEMBL18010380 0.99 HTR7 (0.71) HTR7HTR1AHTR1DHTR1BHTR2A
SCHEMBL18010351 0.99 HTR7 (0.71) HTR7HTR1AHTR1DHTR1BHTR2A
SCHEMBL18010356 0.97 DRD2 (0.67) HTR7HTR1AHTR1DHTR1BHTR2A
SCHEMBL7300518 0.85 HTR7 (0.77) HTR7HTR1AHTR2ADRD2DRD3
SCHEMBL6526368 0.85 DRD2 (0.85) HTR7HTR1AHTR2ADRD2DRD3
SCHEMBL18896514 0.84 HTR7 (0.54) HTR7HTR1AHTR1DHTR1BHTR2A
SCHEMBL18010431 0.83 HTR7 (1.00) HTR7HTR1AHTR1DHTR1BHTR2A
SCHEMBL13875119 0.82 HTR1A (1.00) HTR7HTR1ADRD2DRD3
SCHEMBL25703545 0.82 HTR7 (0.58) HTR7HTR1AHTR1DHTR1BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160244408-A1 CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-08-25 US claimed
WO-2023120963-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING CARBAZOLE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT 한국과학기술연구원 2023-06-29 WO disclosed
WO-2023120963-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING CARBAZOLE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT 한국과학기술연구원 2023-06-29 WO disclosed
US-9663464-B2 Carbazole derivatives acting on 5-HT7 receptor KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-30 US disclosed
US-9663464-B2 Carbazole derivatives acting on 5-HT7 receptor KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-30 US disclosed
US-9663464-B2 Carbazole derivatives acting on 5-HT7 receptor KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-30 US disclosed
US-20160244408-A1 CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-08-25 US disclosed
US-20160244408-A1 CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-08-25 US disclosed
US-20160244408-A1 CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2016-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160244408-A1 CARBAZOLE DERIVATIVES ACTING ON 5-HT7 RECEPTOR HTR7, HTR3A, HTR3B HTR7 1/4885HTR1A 4/4885HTR1D 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.